Please wait while we load the requested 10-K report or click the link below:
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance
– Fourth-Quarter Revenue of $353.9 Million and Full-Year 2015 Revenue of $1.36 Billion –
– Fourth-Quarter GAAP Earnings per Share of $0.69 and Non-GAAP Earnings per Share of $1.00 –
– Full-Year GAAP Earnings per Share of $3.15 and Non-GAAP Earnings per Share of $3.76 –
– Provides 2016 Guidance –
WILMINGTON, Mass.--(BUSINESS WIRE)--February 10, 2016--Charles River Laboratories International, Inc. (NYSE:CRL) today reported its results for the fourth-quarter and full-year 2015 and provided guidance for 2016. For the quarter, revenue from continuing operations was $353.9 million, an increase of 7.4% from $329.5 million in the fourth quarter of 2014. Foreign currency translation reduced reported revenue growth by 3.9%. On a constant-currency basis, revenue growth of 11.3% was driven primarily by the Manufacturing Support and Discovery and Safety Assessment segments. Research Models and Services revenue also increased on a constant-currency basis. The acquisitions of Celsis, ChanTest, Oncotest, and Sunrise Farms contributed 3.4% to consolidated fourth-quarter revenue growth, both on a reported basis and in constant currency.
On a GAAP basis, net income from continuing operations for the fourth quarter of 2015 was $33.3 million, or $0.69 per diluted share, compared to $28.5 million, or $0.59 per diluted share, for the fourth quarter of 2014.
On a non-GAAP basis, net income from continuing operations was $47.3 million for the fourth quarter of 2015, an increase of 22.9% from $38.5 million for the same period in 2014. Fourth-quarter diluted earnings per share on a non-GAAP basis were $1.00, an increase of 23.5% compared to $0.81 per share in the fourth quarter of 2014. The increase was driven primarily by higher revenue and operating margin improvement. The gain from the Company’s limited partnership investments did not have a meaningful impact on earnings per share in the fourth quarter of 2015, compared to a gain of $0.03 per share for the same period in 2014.
The following information was filed by Charles River Laboratories International Inc (CRL) on Wednesday, February 10, 2016 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one year to another to evaluate Charles River Laboratories International Inc's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Charles River Laboratories International Inc.